Browse by ["viewname_eprint_publisher" not defined]

B

Bogdahn, U. and Hau, P. and Olyushin, V. and Mahapatra, A. K. and Parfenov, V. and Venkataramana, N. K. and Wassmann, H. and Ludwig, S. and Heinrichs, H. and Schlingensiepen, K. H. (2008) Targeted therapy with AP 12009 in recurrent or refractory glioblastoma patients: Results of a phase lib study. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 2018. ISSN 0732-183X

Brandes, A. A. and Stupp, R. and Hau, P. and Sleijfer, S. and Lacombe, D. and Gorlia, T. and Yun, H. and Tosoni, A. and Mirimanoff, R. and van den Bent, M. J. (2007) EORTC Study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with or without PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma-Results of a phase I trial. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2026. ISSN 0732-183X, 1527-7755

G

Glas, M. and Koch, H. and Hirschmann, B. and Jauch, T. and Steinbrecher, A. and Bogdahn, U. and Hau, P. (2007) Pegylated liposomal doxorubicin in recurrent high-grade glioma: Comparison of clinical trial results and compassionate use. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2073. ISSN 0732-183X, 1527-7755

H

Hau, P. and Bogdahn, U. and Olyushin, V. E. and Mahapatra, A. and Parfenov, V. E. and Venkataramana, K. and Ludwig, S. and Jachimczak, P. and Heinrichs, H. and Schlingensiepen, K. (2007) Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 12521. ISSN 0732-183X, 1527-7755

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2000. ISSN 0732-183X, 1527-7755

Herrlinger, Ulrich and Schaefer, Nildas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Gies, Martin (2014) Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

J

Jauch, T. and Hau, P. and Bogdahn, U. (2007) Re-challenge with temozolomide (TMZ) at recurrence in high-grade gliomas (HGG). JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2034. ISSN 0732-183X, 1527-7755

S

Stupp, R. and Tosoni, A. and Taal, W. and Hau, P. and Campone, M. and Gijtenbeek, J. and Frenay, M. P. and Gorlia, T. and Lacombe, D. and Brandes, A. A. (2008) Phase II trial of the epothilone analog sagopilone (ZK219477; ZK EPO) in patients with recurrent glioblastoma: Initial report of the EORTC study 26061. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 2015. ISSN 0732-183X

Stupp, Roger and Hegi, Monika E. and Goriia, Thierry and Erridge, Sara and Grujicic, Danica and Steinbach, Joachim Peter and Wick, Wolfgang and Tarnawski, Rafal and Nam, Do-Hyun and Weyerbrock, Astrid and Hau, Peter and Taphoorn, Martin J. B. and Nabors, Louis B. and Reardon, David A. and Van den Bent, Martin J. and Perry, James R. and Hong, Yong Kil and Hicking, Christine and Picard, Martin and Weller, Michael (2013) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation: Final results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2009. ISSN 0732-183X, 1527-7755

Suchorska, Bogdana and Weller, Michael and Tabatabai, Ghazaleh and Senft, Christian and Hau, Peter and Sabel, Michael and Herrlinger, Ulrich and Ketter, Ralf and Schlegel, Uwe S. and Marosi, Christine and Reifenberger, Guido and Wick, Wolfgang and Tonn, Joerg and Wirsching, Hans-Georg (2015) Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial. JOURNAL OF CLINICAL ONCOLOGY, 33 (15supp): 2041. ISSN 0732-183X, 1527-7755

T

Tabatabai, Ghazaleh and Wick, Wolfgang and Reifenberger, Guido and Steinbach, Joachim Peter and Schnell, Oliver and Hau, Peter and Herrlinger, Ulrich and Sabel, Michael and Ketter, Ralf and Schlegel, Uwe S. and Marosi, Christine and Goldbrunner, Roland and Homicsko, Krisztian and Nikkhah, Guido and Pichler, Josef and Vajkoczy, Peter and Meixensberger, Juergen and Weller, Michael (2013) Dose-intensified rechallenge with temozolomide: One week on/one week off versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma (DIRECTOR). JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): TPS2103. ISSN 0732-183X, 1527-7755

Tabatabal, Ghazaleh and Wick, Wolfgang and Steinbach, Joachim Peter and Wick, Antje and Schnell, Oliver and Hau, Peter and Herrlinger, Ulrich and Sabel, Michael and Wlrsching, Hans-Georg and Ketter, Ralf and Baehr, Oliver and Platten, Michael and Tonn, Joerg and Huesing, Johannes and Reifenberger, Guido and Weller, Michael (2014) MGMT promoter methylation as a prognostic biomarker for benefit front dose-intensified temozolomide rechallenge in progressive glioblastoma; First results from the randomized phase II DIRECTOR trial. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

W

Weller, Michael and Reifenberger, Guido and Le Rhun, Emilie and Clarke, Jennifer Leigh and Soffietti, Riccardo and Wick, Antje and Chinot, Olivier L. and Ducray, Francois and Hau, Peter and McDonald, Kerrie Leanne and Marosi, Christine and Schnell, Oliver and Hottinger, Andreas Felix and Reijneveld, Jaap C. and Lombardi, Giuseppe and Wen, Patrick Y. and Klein, Martin and Gorlia, Thierry and Felsberg, Joerg and Hertler, Caroline (2019) Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419). AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

Wick, Wolfgang and Roth, Patrick and Wiestler, Benedikt and Hartmann, Christian and Hau, Peter and Nakamura, Makoto and Stockhammer, Florian and Sabel, Michael and Koeppen, Susanne and Ketter, Ralf and Vajkoczy, Peter and Eyupoglus, Ilker and Kaendler, Stephen and Kalff, Rolf and Galldiks, Norbert and Schmidt-Graf, Friederike and von Deimling, Andreas and Platten, Michael and Reifenberger, Guido and Weller, Michael (2015) Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.